Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Potent calpain inhibitors disclosed by Mitsubishi Chem.

May 1, 1998

Intrathecal SNX-111 for acute postoperative pain

April 30, 1998

Dopaminergic compound CI-1007 evaluated in schizophrenic patients

April 30, 1998

Patient dosing begins in trial of Allelix's selective serotonin agonist

April 30, 1998

Another series of substance P antagonists discovered at Pfizer

April 30, 1998

ABT-431, an improved therapeutic option for PD

April 30, 1998

Roche describes new agents for neurodegenerative disorders

April 30, 1998

Nicotinic agonist shown effective in primate model of PD

April 29, 1998

Treatment of neuropathic pain with gabapentin

April 29, 1998

Org-9487, a new short-acting neuromuscular blocker from Organon

April 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...